申请人:Liu Wenjian
公开号:US20120184508A1
公开(公告)日:2012-07-19
Compounds of formula
and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.
描述了公式化合物及其药用盐,以及含有所述化合物及其药用盐的药物组合物,以及所述化合物和药物组合物用于治疗、控制或改善增生性疾病,包括癌症、唐氏综合征或早发型阿尔茨海默病。